Director Shareholding

GlaxoSmithKline PLC
07 June 2004

                              Director's Interests

Following a re-valuation of the cash element of the notional investment held
within the US Retirement Savings Plan, which is notionally held in GSK Ordinary
Share ADRs, the Administrators of the Plan notified GlaxoSmithKline plc and the
under-mentioned Directors on 7 June 2004 of a decrease in the notional
allocation of Ordinary Share ADRs on 4 June 2004 at a price of $42.37 per 
share: -




Dr J P Garnier                      1
Dr T Yamada                         1



S M Bicknell

Company Secretary

7 June 2004




                      This information is provided by RNS
            The company news service from the London Stock Exchange